Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs Viking Holdings Ltd Ordinary Shares (VIK) Price & Performance

Dr. Reddy's Laboratories Ltd Common StockTrade
Viking Holdings Ltd Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Dr. Reddy's Laboratories Ltd Common Stock vs Viking Holdings Ltd Ordinary Shares — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B), while Viking Holdings Ltd Ordinary Shares trades at $82.22 (market cap $36.89B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 3.5× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Viking Holdings Ltd Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Viking Holdings Ltd Ordinary Shares for 6 Days on average.

RDYVIK
Market Cap
$10.61B$36.89B
Volume
3,738,8695,490,448
Sector
HealthConsumer Cyclical
52-Week High
$15.38$108.26
52-Week Low
$11.38$57.08
Typical Hold Time
0 Days6 Days
Enterprise Value
$10.51B$39.27B
Dividend Yield
0.65%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RDY
100% Buy0% Sell
Avg holding period · 0 Days
VIK

No sentiment data available yet.

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →

About Viking Holdings Ltd Ordinary Shares

Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.

Read more on VIK →